Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Brandi

Showing results (41-50 of 246) with videos related to

Pageof 25
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|August 19, 2020
Immunotherapy in Biliary Tract Cancer: Worthy of a Second LookAngela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology|November 20, 2020
Recent advances of immunotherapy for biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancers|February 4, 2021
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract CancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Future Oncology (London, England)|January 29, 2021
DNA damage response alterations in gastric cancer: knocking down a new wallAngela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2019
Cholangiocarcinoma: Epidemiology and risk factorsShahid A Khan, Simona Tavolari, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology|December 19, 2024
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesityElsa Vitale, Alessandro Rizzo, Oronzo Brunetti, et al.
International Journal of Molecular Sciences|August 23, 2013
Molecular pathways involved in colorectal cancer: implications for disease behavior and preventionDora Colussi, Giovanni Brandi, Franco Bazzoli, et al.
Expert Review of Anticancer Therapy|May 20, 2024
The trend toward more target therapy in pancreatic ductal adenocarcinomaChiara Deiana, Margherita Agostini, Giovanni Brandi, et al.
International Journal of Molecular Sciences|September 28, 2021
The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?Giovanni Brandi, Silvia Turroni, Florencia McAllister, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 16, 2016
Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral centerGiovanni Brandi, Michela Venturi, Maria Abbondanza Pantaleo, et al.
Pageof 25

Showing results (41-50 of 246) with videos related to

Sort By:
Pageof 25
Cancer Control : Journal of the Moffitt Cancer Center|August 19, 2020
Immunotherapy in Biliary Tract Cancer: Worthy of a Second LookAngela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology|November 20, 2020
Recent advances of immunotherapy for biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancers|February 4, 2021
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract CancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Future Oncology (London, England)|January 29, 2021
DNA damage response alterations in gastric cancer: knocking down a new wallAngela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2019
Cholangiocarcinoma: Epidemiology and risk factorsShahid A Khan, Simona Tavolari, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology|December 19, 2024
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesityElsa Vitale, Alessandro Rizzo, Oronzo Brunetti, et al.
International Journal of Molecular Sciences|August 23, 2013
Molecular pathways involved in colorectal cancer: implications for disease behavior and preventionDora Colussi, Giovanni Brandi, Franco Bazzoli, et al.
Expert Review of Anticancer Therapy|May 20, 2024
The trend toward more target therapy in pancreatic ductal adenocarcinomaChiara Deiana, Margherita Agostini, Giovanni Brandi, et al.
International Journal of Molecular Sciences|September 28, 2021
The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?Giovanni Brandi, Silvia Turroni, Florencia McAllister, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 16, 2016
Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral centerGiovanni Brandi, Michela Venturi, Maria Abbondanza Pantaleo, et al.
Pageof 25